About
Ally Bridge Group ("ABG"), founded and led by Frank Yu (previously at Goldman Sachs and Och-Ziff Capital) and based in Hong Kong and New York, is a global life science-dedicated investment firm (www.ally-bridge.com). ABG manages over US$2 billion in life science assets, both private and public, in the U.S., China, and Europe, from medtech to biopharmaceuticals. ABG focuses on investing in the world's most innovative medicines and leading high-impact transactions.
Sector Focus
Healthcare
Ultrasound
Therapy
Series Focus
Series D
Series E
Series F
Cheque Size
$40.0M - $150.0M
Score Breakdown
37Deal Activity
17Track Record
33Visibility
11Profile
100Community
0Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What type of investor is Ally Bridge Group?
Ally Bridge Group ("ABG"), founded and led by Frank Yu (previously at Goldman Sachs and Och-Ziff Capital) and based in Hong Kong and New York, is a global life science-dedicated investment firm (www.ally-bridge.com). ABG manages over US$2 billion in life science assets, both private and public, in the U.S., China, and Europe, from medtech to biopharmaceuticals. ABG focuses on investing in the worl…
What kind of firm is Ally Bridge Group?
Ally Bridge Group is a Private Equity.
What is Ally Bridge Group's assets under management?
Ally Bridge Group manages approximately $2.0B in assets.
Where is Ally Bridge Group based?
Ally Bridge Group is based in Hong Kong.
What sectors does Ally Bridge Group focus on?
Ally Bridge Group focuses on Healthcare, Ultrasound, Therapy.
Similar Investors